Quarterly report pursuant to Section 13 or 15(d)

Business and Viability of Operations (Details Textual)

v3.10.0.1
Business and Viability of Operations (Details Textual)
 1 Months Ended 9 Months Ended 12 Months Ended
Jul. 26, 2018
USD ($)
$ / shares
shares
Sep. 30, 2018
USD ($)
shares
Sep. 30, 2017
USD ($)
Dec. 31, 2017
USD ($)
shares
Dec. 31, 2016
USD ($)
Jul. 23, 2010
shares
Stockholders' Equity, Reverse Stock Split       15-for-1    
Preferred Stock, Shares Authorized | shares   20,000,000   20,000,000    
Common Stock, Shares Authorized | shares   200,000,000   200,000,000    
Common Stock, Shares, Issued | shares   15,366,327   324,821   4,872,221
Preferred Stock, Shares Issued | shares   0   2,762,594   41,438,818
Retained Earnings (Accumulated Deficit)   $ (172,900,973)   $ (108,283,423) [1]    
Cash and Cash Equivalents, at Carrying Value   6,101,561 $ 436,404 $ 249,143 [1] $ 92,262  
Proceeds from Issuance of Common Stock   10,272,679 $ 0      
Payments of Stock Issuance Costs   900,000        
Convertible Preferred Stock, Shares Issued upon Conversion | shares 2,762,594          
Debt Instrument, Convertible, Number of Equity Instruments 9,527,144          
Repayments of Notes Payable $ 200,000          
IPO [Member]            
Shares Issued, Price Per Share | $ / shares $ 5.00          
Proceeds from Issuance of Common Stock $ 10,273,000 $ 10,300,000        
Stock Issued During Period, Value, New Issues $ 12,000,000          
Stock Issued During Period, Shares, New Issues | shares 2,400,000          
Payments for Underwriters Discounts and Commissions $ 900,000          
Payments for Underwriters Accountable and Nonaccountable Expenses 220,000          
Payments of Stock Issuance Costs $ 607,000          
[1] The condensed consolidated balance sheet as of December 31, 2017 was derived from the audited consolidated balance sheet as of that date.